Stopped: Per PI: "Never went to IRB Never recruited anyone Never resubmitted the score NIH application I am leaving the institution"
Double blind randomized controlled parallel pilot trial of Quercetin vs placebo oral administration in 24 postmenopausal women. The study team will conduct a feasibility pilot in preparation for a larger efficacy trial that will test the protective effects of quercetin against cardiac and skeletal muscle dysfunction and changes in structure induced by estrogen loss and potential mechanistic pathways in post-menopausal women at risk of heart failure with preserved ejection fraction (HFPEF).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility: Number of enrolled participants per month
Timeframe: up through 13 months
Eligibility: Proportion eligible after screening
Timeframe: baseline